NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead.
Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year.
Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet.
That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict.
Jason Kelce will join ESPN’s 'Monday Night Countdown,' AP source says
Tens of thousands of Israelis rally in Tel Aviv demanding Gaza hostage deal
Ministers announce advisory group for fast
Chris Hipkins says sick children shouldn't be at school
Chinese FM holds talks with Bolivian counterpart
US defense chief denies genocide committed in Gaza
US Postal Service seeks to hike stamp prices to 73 cents
Russia hits vast dam in war's largest strike on Ukrainian energy infrastructure, Kyiv says
Iconic arch used as Iditarod finish line collapses in Alaska
Truth Social: Trump's DJT stock plummets days after going public